
This webcast and supporting materials were developed by the PCDOS faculty in conjunction with OmniaMed Communications.
Boehringer Ingelheim has provided a sponsorship towards this independent programme. Boehringer Ingelheim has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the Boehringer Ingelheim sponsored symposia.
The bigger picture in focus:
Boehringer Ingelheim sponsored symposium session
This promotional meeting has been developed, organised and funded by Boehringer Ingelheim and is intended for healthcare professionals in the Republic of Ireland only. The speakers have received an honorarium for giving this presentation. Boehringer Ingelheim products will be discussed during this presentation.
Prescribing information for Jardiance® (empagliflozin) can be accessed here
Adverse events should be reported. Reporting forms and information can be found at: https://www.hpra.ie/homepage/about-us/report-an-issue. Adverse events should also be reported to Boehringer Ingelheim Drug Safety on 01 2913960, or by e-mail: PV_local_UK_Ireland@boehringer-ingelheim.com. |
PC-GB-112411 | May 2026

Prof Donal Sexton
Consultant Nephrologist, St James’s Hospital, Dublin
Prof Diarmuid Smith
Consultant Endocrinologist, Beaumont Hospital, Dublin

This webcast and supporting materials were developed by the PCDOS faculty in conjunction with OmniaMed Communications.
Boehringer Ingelheim has provided a sponsorship towards this independent programme. Boehringer Ingelheim has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the Boehringer Ingelheim sponsored symposia.